$162.96
+4.26 (+2.68%)
Last updated: May 31, 2026 04:43
Fundamentals Overview
Illumina, Inc. is near the high of its 52-week range with moderate valuation, trending upward today.
Valuation moderate
Profitability
Risk (Beta)
1.42 — higher vol
Earnings & growth
BullzEye Analysis
Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
Analyst grade: B+ · 3M vs S&P 500: +24.6% · 3M vs Healthcare sector: +39%
Pressures (Sell):
Beta 1.42 (elevated)
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: B+. Current institutional positions: Buy: 3, Equal Weight: 1, Hold: 7, Neutral: 8, Outperform: 4, Overweight: 1, Sell: 1, Underweight: 5.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $-63.17; current price is $162.96. That’s a -138.8% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 29.42 |
| PEG (TTM) | 0.16 |
| P/B (TTM) | 9.32 |
| P/S (TTM) | 5.62 |
| P/FCF (TTM) | 24.93 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 1.75 |
| Quick Ratio (TTM) | 1.36 |
| Cash Ratio (TTM) | 0.7 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 19.43% |
| Gross margin (TTM) | 67.66% |
| Operating margin (TTM) | 21.45% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for ILMN.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| Citigroup | maintain | Sell | Sell | 2026-05-04 |
| Evercore ISI Group | maintain | Outperform | Outperform | 2026-05-01 |
| JP Morgan | maintain | Neutral | Neutral | 2026-05-01 |
| Canaccord Genuity | maintain | Hold | Hold | 2026-05-01 |
| Barclays | maintain | Underweight | Underweight | 2026-05-01 |
| Piper Sandler | maintain | Overweight | Overweight | 2026-02-09 |
| JP Morgan | maintain | Neutral | Neutral | 2026-02-06 |
| Guggenheim | maintain | Buy | Buy | 2026-01-26 |
| Canaccord Genuity | maintain | Hold | Hold | 2026-01-26 |
| Stifel | maintain | Buy | Buy | 2026-01-20 |
| TD Cowen | maintain | Hold | Hold | 2026-01-07 |
| Guggenheim | maintain | Buy | Buy | 2026-01-05 |
| Canaccord Genuity | maintain | Hold | Hold | 2025-12-22 |
| Barclays | maintain | Underweight | Underweight | 2025-12-15 |
| JP Morgan | maintain | Neutral | Neutral | 2025-12-15 |
| Canaccord Genuity | maintain | Hold | Hold | 2025-10-31 |
| TD Cowen | maintain | Hold | Hold | 2025-10-31 |
| Barclays | maintain | Underweight | Underweight | 2025-10-31 |
| JP Morgan | maintain | Neutral | Neutral | 2025-10-31 |
| Baird | maintain | Neutral | Neutral | 2025-10-31 |
| Evercore ISI Group | maintain | Outperform | Outperform | 2025-10-31 |
| UBS | maintain | Neutral | Neutral | 2025-10-31 |
| Evercore ISI Group | maintain | Outperform | Outperform | 2025-10-07 |
| Barclays | maintain | Underweight | Underweight | 2025-10-02 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2025-08-04 |
| RBC Capital | maintain | Outperform | Outperform | 2025-08-01 |
| UBS | maintain | Neutral | Neutral | 2025-08-01 |
| Canaccord Genuity | maintain | Hold | Hold | 2025-08-01 |
| Barclays | maintain | Underweight | Underweight | 2025-08-01 |
| JP Morgan | maintain | Neutral | Neutral | 2025-08-01 |